< Back to previous page
Publication
Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies
Journal Contribution - Journal Article Conference Contribution
Journal: AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN: 0002-9270
Volume: 116
Pages: S357 - S358
Publication year:2021